Synairgen
Synairgen is a University spin-off and public limited company (plc) working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna Davies and . The company develops drugs for respiratory diseases including COVID-19.

A subsidiary of the company, Synairgen Research Limited, works on research and development.
Q7896797
University spin-off
Concept
Q5225895
public limited company
Concept
Q1418791
drug discovery
Concept
Q7108
biotechnology
Concept
Q76473
University of Southampton
ORG
Q1547900
Stephen Holgate
PER
Q62915084
Donna Davies
PER
Q3286546
respiratory disease
Concept
Q84263196
COVID-19
Concept
Q276099
research and development
Concept
Q43895224
Synairgen
ORG
Q43895224
Synairgen
ORG
2003-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2003
DATE
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
industry
inception